The intersection of pharmaceutical engineering, public health policy, and addiction medicine represents one of the most complex arenas in modern healthcare. Among the numerous regulatory and manufacturing interventions introduced over the past few decades, few have generated as much scientific debate and systemic impact as the reformulation of high-dose extended-release opioid medications. Specifically, the structural […]